93
Views
4
CrossRef citations to date
0
Altmetric
Original Research

Deterioration of quality of life is associated with the exacerbation frequency in individuals with alpha-1-antitrypsin deficiency – analysis from the German Registry

, , , , , & show all
Pages 1427-1437 | Published online: 12 May 2017

References

  • LaurellCBErikssonSThe electrophoretic alpha1-globulin pattern of serum in alpha1-antitrypsin deficiencyScan J Clin Lab Invest196315132140
  • FregoneseLStolkJHereditary alpha-1-antitrypsin deficiency and its clinical consequencesOrphanet J Rare Dis200831618565211
  • BlancoIde SerresFJFernandez-BustilloELaraBMiravitllesMEstimated numbers and prevalence of PI*S and PI*Z alleles of alpha1-antitrypsin deficiency in European countriesEur Respir J2006271778416387939
  • LuisettiMCampoIScabiniRThe problems of clinical trials and registries in rare diseasesRespir Med2010104Suppl 14244
  • FähndrichSHerrCGreulichTSex differences in alpha-1-antitrypsin deficiency lung disease-analysis from the German registryCOPD201512Suppl 1586225938294
  • JonesPWQuirkFHBaveystockCMLittlejohnsPA self-complete measure of health status for chronic airflow limitation. The St. George’s Respiratory QuestionnaireAm Rev Respir Dis19921456132113271595997
  • Domingo-SalvanyALamarcaRFerrerMHealth-related quality of life and mortality in male patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med2002166568068512204865
  • WilkeSJonesPWMullerovaHOne-year change in health status and subsequent outcomes in COPDThorax201570542042525782757
  • SeemungalTADonaldsonGCPaulEABestallJCJeffriesDJWedzichaJAEffect of exacerbation on quality of life in patients with chronic obstructive pulmonary diseaseAm J Respir Crit Care Med19981575 Pt 1141814229603117
  • KetelaarsCASchlosserMAMostertRDeterminants of health-related quality of life in patients with chronic obstructive pulmonary diseaseThorax199651139438658367
  • GauvainCMornexJFPisonCHealth-related quality of life in patients with alpha-1 antitrypsin deficiency: the French experienceCOPD201512Suppl 14651
  • BradiACAudishoNCaseyDKChapmanKRAlpha-1 antitrypsin deficiency in Canada: regional disparities in diagnosis and managementCOPD201512Suppl 1152125938286
  • CamposMAAlazemiSZhangGExacerbations in subjects with alpha-1 antitrypsin deficiency receiving augmentation therapyRespir Med2009103101532153919464158
  • NeedhamMStockleyRAExacerbations in {alpha}1-antitrypsin deficiencyEur Respir J2005256992100015929953
  • CazzolaMHananiaNAMacNeeWRüdellKHackfordCTamimiNA review of the most common patient-reported outcomes in COPD – revisiting current knowledge and estimating future challengesInt J Chronic Obstr201510725738
  • MarinJMCoteCGDiazOPrognostic assessment in COPD: health related quality of life and the BODE indexRespir Med2011105691692121282050
  • MancaSRodriguezEHuertaAUsefulness of the CAT, LCOPD, EQ-5D and COPDSS scales in understanding the impact of lung disease in patients with alpha-1 antitrypsin deficiencyCOPD201411548048824832005
  • MehtaAJMiedingerDKeidelDOccupational exposure to dusts, gases, and fumes and incidence of chronic obstructive pulmonary disease in the Swiss Cohort Study on Air Pollution and Lung and Heart Diseases in AdultsAm J Respir Crit Care Med2012185121292130022492989
  • NagaiKMakitaHSuzukiMDifferential changes in quality of life components over 5 years in chronic obstructive pulmonary disease patientsInt J Chron Obstruct Pulmon Dis20151074575725914531
  • DowsonLJGuestPJStockleyRALongitudinal changes in physiological, radiological, and health status measurements in alpha(1)-antitrypsin deficiency and factors associated with declineAm J Respir Crit Care Med200116410 Pt 11805180911734427
  • JonesPWInterpreting thresholds for a clinically significant change in health status in asthma and COPDEur Respir J200219339840411936514